114 related articles for article (PubMed ID: 33141782)
1. Estimated Proportions and Characteristics of National Survey Respondents Reporting New Diagnoses of Schizophrenia or Other Psychoses in the Past Year as Compared With Prior Years.
Bommersbach T; Rhee TG; Stefanovics E; Rosenheck R
J Nerv Ment Dis; 2021 Jan; 209(1):65-70. PubMed ID: 33141782
[TBL] [Abstract][Full Text] [Related]
2. Comorbidity of Axis I and II mental disorders with schizophrenia and psychotic disorders: findings from the National Epidemiologic Survey on Alcohol and Related Conditions.
McMillan KA; Enns MW; Cox BJ; Sareen J
Can J Psychiatry; 2009 Jul; 54(7):477-86. PubMed ID: 19660170
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic stability four years after a first episode of psychosis.
Whitty P; Clarke M; McTigue O; Browne S; Kamali M; Larkin C; O'Callaghan E
Psychiatr Serv; 2005 Sep; 56(9):1084-8. PubMed ID: 16148321
[TBL] [Abstract][Full Text] [Related]
4. Predictors of psychosis remission in psychotic disorders that co-occur with substance use.
Caton CL; Hasin DS; Shrout PE; Drake RE; Dominguez B; Samet S; Schanzer B
Schizophr Bull; 2006 Oct; 32(4):618-25. PubMed ID: 16873441
[TBL] [Abstract][Full Text] [Related]
5. First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol.
Green AI; Tohen MF; Hamer RM; Strakowski SM; Lieberman JA; Glick I; Clark WS;
Schizophr Res; 2004 Feb; 66(2-3):125-35. PubMed ID: 15061244
[TBL] [Abstract][Full Text] [Related]
6. Chronology of comorbid and principal syndromes in first-episode psychosis.
Strakowski SM; Keck PE; McElroy SL; Lonczak HS; West SA
Compr Psychiatry; 1995; 36(2):106-12. PubMed ID: 7758295
[TBL] [Abstract][Full Text] [Related]
7. Prescription Opioid Misuse in US Older Adults: Associated Comorbidities and Reduced Quality of Life in the National Epidemiologic Survey of Alcohol and Related Conditions-III.
Schepis TS; McCabe SE
J Clin Psychiatry; 2019 Nov; 80(6):. PubMed ID: 31747489
[TBL] [Abstract][Full Text] [Related]
8. Suicidality before and in the early phases of first episode psychosis.
Barrett EA; Sundet K; Faerden A; Nesvåg R; Agartz I; Fosse R; Mork E; Steen NE; Andreassen OA; Melle I
Schizophr Res; 2010 Jun; 119(1-3):11-7. PubMed ID: 20399077
[TBL] [Abstract][Full Text] [Related]
9. Cannabis and Alcohol Abuse Among First Psychotic Episode Inpatients.
Katz G; Kunyvsky Y; Hornik-Lurie T; Raskin S; Abramowitz MZ
Isr J Psychiatry Relat Sci; 2016; 53(3):10-15. PubMed ID: 28492376
[TBL] [Abstract][Full Text] [Related]
10. Using brief self-reports and clinician scales to screen for substance use disorders in psychotic patients.
Møller T; Linaker OM
Nord J Psychiatry; 2010 Apr; 64(2):130-5. PubMed ID: 19883188
[TBL] [Abstract][Full Text] [Related]
11. Lifetime prevalence, demographic risk factors, and diagnostic validity of nonaffective psychosis as assessed in a US community sample. The National Comorbidity Survey.
Kendler KS; Gallagher TJ; Abelson JM; Kessler RC
Arch Gen Psychiatry; 1996 Nov; 53(11):1022-31. PubMed ID: 8911225
[TBL] [Abstract][Full Text] [Related]
12. Drug and alcohol use among patients with schizophrenia and related psychoses: levels and consequences.
Margolese HC; Malchy L; Negrete JC; Tempier R; Gill K
Schizophr Res; 2004 Apr; 67(2-3):157-66. PubMed ID: 14984874
[TBL] [Abstract][Full Text] [Related]
13. Do substance type and diagnosis make a difference? A study of remission from alcohol- versus drug-use disorders using the National Epidemiologic Survey on Alcohol and Related Conditions.
Karno MP; Grella CE; Niv N; Warda U; Moore AA
J Stud Alcohol Drugs; 2008 Jul; 69(4):491-5. PubMed ID: 18612563
[TBL] [Abstract][Full Text] [Related]
14. Comorbidity of severe psychotic disorders with measures of substance use.
Hartz SM; Pato CN; Medeiros H; Cavazos-Rehg P; Sobell JL; Knowles JA; Bierut LJ; Pato MT;
JAMA Psychiatry; 2014 Mar; 71(3):248-54. PubMed ID: 24382686
[TBL] [Abstract][Full Text] [Related]
15. The association between substance misuse and first-episode psychosis in a defined UK geographical area during the 1990s.
Donoghue K; Medley I; Brewin J; Glazebrook C; Mason P; Cantwell R; Jones PB; Harrison G; Doody GA
Soc Psychiatry Psychiatr Epidemiol; 2011 Feb; 46(2):137-42. PubMed ID: 20043146
[TBL] [Abstract][Full Text] [Related]
16. McLean OnTrack: a transdiagnostic program for early intervention in first-episode psychosis.
Shinn AK; Bolton KW; Karmacharya R; Lewandowski KE; Yuksel C; Baker JT; Chouinard VA; Pingali SM; Bye H; Cederbaum K; Öngür D
Early Interv Psychiatry; 2017 Feb; 11(1):83-90. PubMed ID: 26616380
[TBL] [Abstract][Full Text] [Related]
17. Medical comorbidity in patients with schizophrenia and alcohol dependence.
Batki SL; Meszaros ZS; Strutynski K; Dimmock JA; Leontieva L; Ploutz-Snyder R; Canfield K; Drayer RA
Schizophr Res; 2009 Feb; 107(2-3):139-46. PubMed ID: 19022627
[TBL] [Abstract][Full Text] [Related]
18. Psychotic patients with unclear diagnoses. A descriptive analysis.
Fennig S; Bromet EJ; Craig T; Jandorf L; Schwartz JE
J Nerv Ment Dis; 1995 Apr; 183(4):207-13. PubMed ID: 7714509
[TBL] [Abstract][Full Text] [Related]
19. Conditional substance abuse and dependence by diagnosis of mood or anxiety disorder or schizophrenia in the U.S. population.
Martins SS; Gorelick DA
Drug Alcohol Depend; 2011 Dec; 119(1-2):28-36. PubMed ID: 21641123
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and severity of substance use disorders and onset of psychosis in first-admission psychotic patients.
Rabinowitz J; Bromet EJ; Lavelle J; Carlson G; Kovasznay B; Schwartz JE
Psychol Med; 1998 Nov; 28(6):1411-9. PubMed ID: 9854282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
